Antidepressant use and cognitive deficits in older men: Addressing confounding by indications with different methods

Annals of Epidemiology

Volumn 22, Issue 1, 2012, Pages 9-16

  Han, Ling ^a   Kim, Nancy ^a,b   Brandt, Cynthia ^a,b   Allore, Heather G ^a  

^a YALE UNIVERSITY   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Antidepressant Use; Cognitive Deficit; Confounding by Indication; Elderly; Multiple Linear Regression; Structural Equation Modeling

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; NORTRIPTYLINE; SERTRALINE; TRAZODONE;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG USE; HOPKINS VERBAL LEARNING TEST; HUMAN; HYPERTENSION; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM; TECHNIQUE;

AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONNECTICUT; DEPRESSION; HUMANS; HYPERTENSION; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; PREVALENCE; PROPENSITY SCORE; VETERANS;

EID: 83055180691     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2011.10.004     Document Type: Article

References (36)

1. Collet J.P., Boivin J.F. Bias and confounding in pharmacoepidemiology. Pharmacoepidemiology 2000, 765-784. John Wiley & Sons, Inc., New York. B.L. Strom (Ed.).
2. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
3. Salas M., Hofman A., Stricker B.H. Confounding by indication: An example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999, 149:981-983.
4. Glynn R.J., Schneeweiss S., Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology [review]. Basic Clin Pharmacol Toxicol 2006, 98:253-259.
5. Shah B.R., Laupacis A., Hux J.E., Austin P.C. Propensity score methods gave similar results to traditional regression modeling in observational studies: A systematic review [review]. J Clin Epidemiol 2005, 58:550-559.
6. Kline R.B. Principles and Practice of Structural Equation Modeling 2004, Guilford Press, New York. 2nd ed.
7. MacCallum R.C., Austin J.T. Application of structural equation modeling in psychological research. Ann Rev Psychol 2000, 51:201-236.
8. MacKinnon D.P., Fairchild A.J., Fritz M.S. Mediation analysis. Ann Rev Psychol 2007, 58:593-614.
9. Cadell S., Regehr C., Hemsworth D. Factors contributing to posttraumatic growth: a proposed structural equation model. Am J Orthopsychiatry 2003, 73:279-287.
10. Amado-Boccara I., Gougoulis N., Poirier Littre M.F., Galinowski A., Loo H. Effects of antidepressants on cognitive functions: A review [review]. Neurosci Biobehav Rev 1995, 19:479-493.
11. Oxman T.E. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 1996, 57:38-44.
12. Butters M.A., Becker J.T., Nebes R.D., Zmuda M.D., Mulsant B.H., Pollock B.G., et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000, 157:1949-1954.
13. Doraiswamy P.M., Krishnan R.R., Oxman T., Jenkyn L.R., Coffey D.J., Burt T., et al. Does antidepressant therapy improve cognition in elderly depressed patients?. J Gerontol Biol Sci Med Sci 2003, 58A:1137-1144.
14. Ackermann R.T., Williams J.W. Rational treatment choices for non-major depressions in primary care. An evidence-based review. J Gen Intern Med 2002, 17:293-301.
15. Han L., McCusker J., Cole M., Capek R., Abrahamowicz M. Antidepressant use and cognitive function in older medical patients with major or minor depression-a prospective cohort study with database linkage. J Clin Psychopharmacol 2011, 31:429-435.
16. Agostini J.V., Tinetti M.E., Han L., Peduzzi P., Foody J.M., Concato J. Association between antihypertensive medication use and non-cardiovascular outcomes in older men. J Gen Intern Med 2007, 22:1661-1667.
17. Han L., Agostini J.V., Allore H.A. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriat Soc 2008, 56:2203-2210.
18. Brandt J. Development of a new memory test with six equivalent forms. Clin Neuropsychol 1991, 5:125-142. The Hopkins Verbal Learning Test.
19. Kuslansky G., Katz M., Verghese J., Hall C., Buschke H., Lapuerta P., et al. Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination. Arch Clin Neuropsychol 2004, 19:89-104.
20. Beatty W.W., Butters N., Janowsky D.S. Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia. Behav Neur Biol 1986, 45:196-211.
21. Han L., McCusker J., Cole M., Abrahamowicz M., Primeau F., Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001, 161:1099-1105.
22. Paterniti S., Dufouil C., Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: The Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002, 22:285-293.
23. Dealberto M.J., Mcavay G.J., Seeman T., Berkman L. Psychotropic drug use and cognitive decline among older men and women. Int J Geriat Psychiatry 1997, 12:567-574.
24. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413-2446. Joint National Committee.
25. Prince M.J. The treatment of hypertension in older people and its effect on cognitive function [review]. Biomed Pharmacother 1997, 51:208-212.
26. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association Press, Washington DC. 4th ed.
27. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measurement 1977, 1:385-401.
28. Fillenbaum G.G. Multidimensional functional assessment of older adults: The Duke Older Americans Resources and Services procedures 1988, Lawrence Erlbaum Associates, Inc., Hillsdale, NJ.
29. Charlson M.E., Pompei P., Ales K.L., MacKenzie R.C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
30. Hennessy S., Bilker W.B., Leonard C.E., Chittams J., Palumbo C.M., Karlawish J.H., et al. Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol 2007, 60:911-918.
31. Shrout P.E., Bolger N. Mediation in experimental and non-experimental studies: new procedures and recommendations. Psychol Methods 2002, 7:422-445.
32. McCulloch C.E., Searle S.R. Generalized, linear and mixed models 2001, John Wiley & Sons, Inc., New York.
33. SAS OnlineDoc® 9.2 2007, SAS Institute Inc., Cary, NC.
34. Han L., McCusker J., Cole M., Abrahamowicz M., Caoek R. 12-month cognitive outcome of major and minor depression in older medical patients. Am J Geriatr Psychiat 2008, 16:742-751.
35. Sturmer T., Joshi M., Robert J., Glynn R.J., Avorn J., Rothman K.J., et al. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006, 59:437-447.
36. Cole S.R., Hernan M.A. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008, 168:656-664.